ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2019 and some content may be unavailable. To unlock all content for 2019, please visit the archives.

Abstract: FR-PO050

The Effect of Therapeutic Hypothermia on Urine Output After Cardiopulmonary Resuscitation

Session Information

  • AKI: Clinical Outcomes, Trials
    November 08, 2019 | Location: Exhibit Hall, Walter E. Washington Convention Center
    Abstract Time: 10:00 AM - 12:00 PM

Category: Acute Kidney Injury

  • 102 AKI: Clinical, Outcomes, and Trials

Author

  • Lee, MinJeong, Ajou University School of Medicine, Suwon, Korea (the Republic of)
Background

Therapeutic temperature management (TTM) was strongly recommended by the 2015 International Lision Committee on Resuscitation as a component of post-resuscitation care. It has been known to be effective in improving the survival rate and neurologic functional outcome of patients after cardiac arrest. While commonly described cold diuresis, renal tubular function is diminished in the induction and maintenance phase of TTM, few studies have characterized cold-induced diuresis or rewarm anti-diuresis during TTM. In this study, we sought to characterize urine output changes during postcardiac arrest therapeutic hypothermia.

Methods

We conducted retrospective cohort study to determine urine output changes during TTM of the postcardiac arrest patients. We analyzed 104 patients who underwent all phase TTM for 3 years from Jan 1, 2012 to Dec 31, 2014. We calculated the hourly IV fluid input and urine output rates for each TTM phase. We fit a generalized linear mixed model with each TTM phase as a categorical variable to compare the urine output at each phase of analysis.

Results

Four-fifths of the patients suffered out-of-hospital arrest. Approximately 70% survived to hospital discharge. Urine output rate was highest at 249.1 ± 255.7 mL/hr in the hypothermia induction phase but lowest at 96.4 ± 65.3 mL/hr during rewarming phase even though total I/O showed the most positive balance during the rewarming phase.

Conclusion

We observed modest increases in urine output during induction phase of TTM. This has important implications for fluid management in patients undergoing therapeutic hypothermia. We will collabrate with the statistics team to analyze changes in continuous urine output and overall I / O data rather than average data of the larger number of patients.

Fluid input and output during therapeutic hypothermia
 Hypothermia
induction
Hypothermia
maintenance
Hypothermia
rewarm
Post-rewarm
P-value
IV fluid input (mean, mlL/hour)
300.5 ± 189.1
206.7 ± 92.3
181.9 ± 77.5
165.0 ± 63.7
<0.001
Urine Output (mean, mL/hour)
249.1 ± 255.7
130.4 ± 97.5
96.4 ± 65.3
119.9 ± 72.7
<0.001
Output except urine output (mean, mL/hour)
15.8 ± 94.2
3.5 ± 8.6
3.5 ± 7.7
4.1 ± 8.5
0.193
Total Output (mean, mL/hour)
264.9 ± 259.9
133.9 ± 98.1
99.9 ± 67.1
124.0 ± 71.7
<0.001
Total I/O balance (mean, mL/hour)
35.7 ± 261.8
72.8 ± 92.2
82.9 ± 81.8
39.6 ± 73.2
0.081
MAP (mmHg)
107.0 ± 26.2
95.6 ± 11.6
89.8 ± 11.8
89.6 ± 12.7
<0.001